Dr. Parvathaneni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific St
Seattle, WA 98195Phone+1 206-598-4100
Education & Training
- University of Texas M.D. Anderson Cancer Center2005 - 2006
- Residency program of Royal Australian and New Zealand College of RadiologistsFRANZCR, 1998 - 2003
- Rajah Muthiah Medical CollegeClass of 1993
Certifications & Licensure
- WA State Medical License 2006 - 2026
- American Board of Radiology Radiation Oncology
- Fellow of Royal Australian and New Zealand College of RadiologistsRadiation Oncology
Awards, Honors, & Recognition
- Annual Faculty Teaching Award University of Washington, Department of Radiation Oncology, 2007
- Best Outgoing Student Annamalai University, 1993
- First rank in Preclinical Subjects Annamalai University, 1988
Clinical Trials
- L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- Complications of intravascular brachytherapy.Kent Wallner, Kathleen E Kearney, Lorenzo Azzalini, Edward Y Kim, Upendra Parvathaneni
Brachytherapy. 2024-12-09 - Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint in...Cassie Pan, Kevin Ng, Jenna Voutsinas, Brittany Barber, Zain H Rizvi
BMC Cancer. 2024-11-15 - 1 citationsIncreased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma.Nora A Alexander, Stephanie K Schaub, Peter H Goff, Daniel S Hippe, Song Y Park
Journal of the American Academy of Dermatology. 2024-02-01
Journal Articles
- Patterns of Cervical Node Positivity, Regional Failure Rates, and Fistula Rates for HPV+ Oropharyngeal Squamous Cell Carcinoma Treated with Transoral Robotic Surgery (...Jeffrey J Houlton, Sapna Patel, Upendra Parvathaneni, Eduardo Mendez, Neal D Futran, ScienceDirect
- Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients with Merkel Cell CarcinomaUpendra Parvathaneni, David M Koelle, David Byrd, Shailender Bhatia, Michi Shinohara, Clinical Cancer Research
- A Novel Single-fraction Radiotherapy approach for metastatic Merkel cell carcinoma is well tolerated and demonstrates strong efficacy linked to intact cellular immunityParvathaneni U, Iyer J, Miller N, et al., Int J Radiat Oncol Phys Biol 90 (1) S758, 2014, 9/2014
- Join now to see all
Books/Book Chapters
Professional Memberships
- Member
Other Languages
- Hindi, Tamil, Telugu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: